-
Journal of the American Heart... Aug 2021
Topics: Peer Review; Publishing
PubMed: 34278832
DOI: 10.1161/JAHA.121.021475 -
PLoS Biology Dec 2022As 2022 draws to a close, we look back at some of the recent changes that have taken place at PLOS Biology, highlight some of our editors' favorite moments from the past...
As 2022 draws to a close, we look back at some of the recent changes that have taken place at PLOS Biology, highlight some of our editors' favorite moments from the past year across the life sciences, and thank our editors, authors and peer-reviewers.
Topics: Peer Review, Research; Biological Science Disciplines
PubMed: 36525462
DOI: 10.1371/journal.pbio.3001957 -
EMBO Reports Dec 2019EMBO Press and ASAPbio launch Review Commons, a platform to provide authors with journal-independent peer review of their manuscripts and preprints.
EMBO Press and ASAPbio launch Review Commons, a platform to provide authors with journal-independent peer review of their manuscripts and preprints.
Topics: Biomedical Research; Editorial Policies; Humans; Peer Review, Research; Publishing
PubMed: 31789446
DOI: 10.15252/embr.201949663 -
Diagnostic and Interventional Imaging Jan 2022
Topics: Humans; Peer Review, Research
PubMed: 34991878
DOI: 10.1016/j.diii.2021.12.001 -
ELife Oct 2022eLife is changing its editorial process to emphasize public reviews and assessments of preprints by eliminating accept/reject decisions after peer review.
eLife is changing its editorial process to emphasize public reviews and assessments of preprints by eliminating accept/reject decisions after peer review.
Topics: Peer Review, Research; Publishing
PubMed: 36263932
DOI: 10.7554/eLife.83889 -
Radiologia 2023
Topics: Authorship; Disclosure; Peer Review
PubMed: 37758329
DOI: 10.1016/j.rxeng.2023.05.004 -
Nature Communications Oct 2022Starting in 2016, we have offered authors the option to publish the comments received from the reviewers and their responses alongside the paper. As we believe that...
Starting in 2016, we have offered authors the option to publish the comments received from the reviewers and their responses alongside the paper. As we believe that transparency strengthens the quality of peer review, we are now moving to publish the exchanges between authors and reviewers for all research articles submitted from November 2022 onward and accepted for publication. Referees will still have the option to remain completely anonymous, to sign their reports, and/or to choose to be acknowledged by name as part of our reviewer recognition scheme.
Topics: Peer Review, Research; Periodicals as Topic
PubMed: 36261430
DOI: 10.1038/s41467-022-33056-8 -
Communications Biology 2019The theme of this year's Peer Review Week, Quality in Peer Review, reflects both the necessity of peer review and the growing uncertainty about its role in scholarly...
The theme of this year's Peer Review Week, Quality in Peer Review, reflects both the necessity of peer review and the growing uncertainty about its role in scholarly publishing. We support peer review that aims to improve manuscripts through critical evaluation before publication.
Topics: Humans; Peer Review; Scholarly Communication
PubMed: 31552304
DOI: 10.1038/s42003-019-0603-3 -
ELife Jan 2020As Eve Marder stands down as a Deputy Editor of , she reflects on the need for journals to change and respond to their environment.
As Eve Marder stands down as a Deputy Editor of , she reflects on the need for journals to change and respond to their environment.
Topics: Biological Science Disciplines; Peer Review, Research; Periodicals as Topic; Publishing
PubMed: 31931957
DOI: 10.7554/eLife.54265 -
Molecular Oncology Jan 2020May 2020 be a rewarding year of change. The recent commitment of the European Commission and policymakers to fight cancer in partnership is expected to bring forward the...
May 2020 be a rewarding year of change. The recent commitment of the European Commission and policymakers to fight cancer in partnership is expected to bring forward the changes long required in the field. Molecular Oncology will stay at the forefront of all developments in the area of oncology by providing a flexible platform for European and International cancer research.
Topics: History, 21st Century; Humans; Medical Oncology; Neoplasms; Peer Review, Research; RNA, Untranslated
PubMed: 31904917
DOI: 10.1002/1878-0261.12613